TreeWAS – Variant ID: rs296390

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K80.2 Calculus of gallbladder without cholecystitis	0.000	0.000	1.000
K80.1 Calculus of gallbladder with other cholecystitis	0.000	0.000	1.000
K80 Cholelithiasis	0.000	0.000	1.000
K82 Other diseases of gallbladder	0.000	0.000	1.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.000	0.001	0.999
K82.8 Other specified diseases of gallbladder	0.000	0.006	0.994
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.008	0.992
K82.4 Cholesterolosis of gallbladder	0.000	0.024	0.976
K82.9 Disease of gallbladder, unspecified	0.000	0.040	0.960
K81 Cholecystitis	0.000	0.074	0.926
K82.2 Perforation of gallbladder	0.000	0.128	0.872
K80.0 Calculus of gallbladder with acute cholecystitis	0.000	0.136	0.864
K81.9 Cholecystitis, unspecified	0.000	0.144	0.856
K82.1 Hydrops of gallbladder	0.000	0.198	0.802
K81.0 Acute cholecystitis	0.000	0.233	0.767
K80.4 Calculus of bile duct with cholecystitis	0.000	0.242	0.758
K82.3 Fistula of gallbladder	0.000	0.244	0.756
K83 Other diseases of biliary tract	0.000	0.264	0.736
K80.3 Calculus of bile duct with cholangitis	0.000	0.283	0.717
K82.0 Obstruction of gallbladder	0.000	0.283	0.717
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.000	0.283	0.716
K81.8 Other cholecystitis	0.000	0.314	0.686
K83.8 Other specified diseases of biliary tract	0.000	0.402	0.598
K83.9 Disease of biliary tract, unspecified	0.000	0.411	0.589
K81.1 Chronic cholecystitis	0.000	0.428	0.572
K83.1 Obstruction of bile duct	0.000	0.435	0.565
K83.4 Spasm of sphincter of Oddi	0.000	0.472	0.528
K83.3 Fistula of bile duct	0.000	0.472	0.528
K83.2 Perforation of bile duct	0.000	0.472	0.528
K80.8 Other cholelithiasis	0.000	0.479	0.521
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.000	0.486	0.514
K87.1 Disorders of pancreas in diseases classified elsewhere	0.000	0.486	0.514
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.000	0.486	0.514
K83.5 Biliary cyst	0.000	0.553	0.447
K85 Acute pancreatitis	0.000	0.586	0.414
K83.0 Cholangitis	0.000	0.618	0.382
K85.1 Biliary acute pancreatitis	0.000	0.684	0.315
K85.3 Drug-induced acute pancreatitis	0.000	0.703	0.297
K85.0 Idiopathic acute pancreatitis	0.000	0.703	0.297
K85.8 Other acute pancreatitis	0.000	0.721	0.279
K85.9 Acute pancreatitis, unspecified	0.000	0.808	0.192
K86 Other diseases of pancreas	0.000	0.813	0.187
K85.2 Alcohol-induced acute pancreatitis	0.001	0.814	0.185
K86.2 Cyst of pancreas	0.000	0.863	0.137
K86.3 Pseudocyst of pancreas	0.000	0.875	0.125
K86.9 Disease of pancreas, unspecified	0.000	0.882	0.118
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.892	0.108
K86.8 Other specified diseases of pancreas	0.000	0.920	0.080
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.056	0.944	0.000
K86.1 Other chronic pancreatitis	0.000	0.947	0.053
K26 Duodenal ulcer	0.032	0.968	0.000
K26.7 Chronic without haemorrhage or perforation	0.029	0.971	0.000
K26.0 Acute with haemorrhage	0.028	0.972	0.000
K26.1 Acute with perforation	0.026	0.974	0.000
K26.2 Acute with both haemorrhage and perforation	0.025	0.975	0.000
K26.5 Chronic or unspecified with perforation	0.025	0.975	0.000
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.023	0.977	0.000
L81.4 Other melanin hyperpigmentation	0.016	0.984	0.000
K29.5 Chronic gastritis, unspecified	0.000	0.985	0.015
E16.2 Hypoglycaemia, unspecified	0.013	0.987	0.000
K26.4 Chronic or unspecified with haemorrhage	0.012	0.987	0.000
Z63.4 Disappearance and death of family member	0.000	0.990	0.010
C77.1 Intrathoracic lymph nodes	0.010	0.990	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.010	0.990	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.009	0.991	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.009	0.991	0.000
Z63 Other problems related to primary support group, including family circumstances	0.000	0.991	0.009
E16 Other disorders of pancreatic internal secretion	0.008	0.992	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.008	0.992	0.000
Z63.0 Problems in relationship with spouse or partner	0.000	0.992	0.008
Z63.5 Disruption of family by separation and divorce	0.000	0.993	0.007
E21.0 Primary hyperparathyroidism	0.007	0.993	0.000
Z63.7 Other stressful life events affecting family and household	0.000	0.993	0.007
T36-T50 Poisoning by drugs, medicaments and biological substances	0.007	0.993	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.007	0.993	0.000
T39.0 Salicylates	0.007	0.993	0.000
K26.3 Acute without haemorrhage or perforation	0.006	0.993	0.001
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.007	0.993	0.000
T39.1 4-Aminophenol derivatives	0.007	0.993	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.007	0.993	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.993	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.993	0.000
T39.2 Pyrazolone derivatives	0.006	0.993	0.000
Z63.8 Other specified problems related to primary support group	0.000	0.993	0.006
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.993	0.000
Z63.9 Problem related to primary support group, unspecified	0.000	0.994	0.006
Z63.6 Dependent relative needing care at home	0.000	0.994	0.006
Z63.3 Absence of family member	0.000	0.994	0.006
Z63.2 Inadequate family support	0.000	0.994	0.006
Z63.1 Problems in relationship with parents and in-laws	0.000	0.994	0.006
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.006	0.994	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.006	0.994	0.000
E16.4 Abnormal secretion of gastrin	0.006	0.994	0.000
E16.3 Increased secretion of glucagon	0.006	0.994	0.000
T50.8 Diagnostic agents	0.006	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
T50.5 Appetite depressants	0.006	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
T50.1 Loop [high-ceiling] diuretics	0.006	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.006	0.994	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.006	0.994	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.994	0.006
E16.1 Other hypoglycaemia	0.006	0.994	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.006	0.994	0.000
N62 Hypertrophy of breast	0.006	0.994	0.000
T47.0 Histamine H(2)-receptor antagonists	0.006	0.994	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.005	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.005	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.005	0.994	0.000
Z48.8 Other specified surgical follow-up care	0.005	0.995	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.005	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
T44.0 Anticholinesterase agents	0.005	0.995	0.000
T36 Poisoning by systemic antibiotics	0.005	0.995	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
T47.7 Emetics	0.005	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.005	0.995	0.000
T47.5 Digestants	0.005	0.995	0.000
T47.4 Other laxatives	0.005	0.995	0.000
T47.3 Saline and osmotic laxatives	0.005	0.995	0.000
T47.2 Stimulant laxatives	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
Z29.2 Other prophylactic chemotherapy	0.005	0.995	0.000
N89.6 Tight hymenal ring	0.000	0.995	0.005
T46.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
T38.7 Androgens and anabolic congeners	0.005	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
T38.5 Other oestrogens and progestogens	0.005	0.995	0.000
T38.4 Oral contraceptives	0.005	0.995	0.000
T38.2 Antithyroid drugs	0.005	0.995	0.000
T38.1 Thyroid hormones and substitutes	0.005	0.995	0.000
T38.0 Glucocorticoids and synthetic analogues	0.005	0.995	0.000
E21.3 Hyperparathyroidism, unspecified	0.005	0.995	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.995	0.000
T46.7 Peripheral vasodilators	0.004	0.995	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.995	0.000
N89 Other noninflammatory disorders of vagina	0.000	0.995	0.005
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.996	0.004
N89.5 Stricture and atresia of vagina	0.000	0.996	0.004
E21.5 Disorder of parathyroid gland, unspecified	0.004	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
T41.5 Therapeutic gases	0.004	0.996	0.000
T41.4 Anaesthetic, unspecified	0.004	0.996	0.000
T41.3 Local anaesthetics	0.004	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
T41.1 Intravenous anaesthetics	0.004	0.996	0.000
T41.0 Inhaled anaesthetics	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
T48.4 Expectorants	0.004	0.996	0.000
T48.3 Antitussives	0.004	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
T48.0 Oxytocic drugs	0.004	0.996	0.000
T49.9 Topical agent, unspecified	0.004	0.996	0.000
T49.8 Other topical agents	0.004	0.996	0.000
T49.7 Dental drugs, topically applied	0.004	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.996	0.000
T49.2 Local astringents and local detergents	0.004	0.996	0.000
T49.1 Antipruritics	0.004	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
F80.1 Expressive language disorder	0.004	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
T36.8 Other systemic antibiotics	0.004	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
T36.6 Rifamycins	0.004	0.996	0.000
T36.5 Aminoglycosides	0.004	0.996	0.000
T36.4 Tetracyclines	0.004	0.996	0.000
T36.3 Macrolides	0.004	0.996	0.000
T36.2 Chloramphenicol group	0.004	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.004	0.996	0.000
E21.4 Other specified disorders of parathyroid gland	0.004	0.996	0.000
E21.2 Other hyperparathyroidism	0.004	0.996	0.000
F11 Mental and behavioural disorders due to use of opioids	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.004	0.996	0.000
F43.2 Adjustment disorders	0.004	0.996	0.000
Z29.8 Other specified prophylactic measures	0.004	0.996	0.000
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.000	0.996	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.004	0.996	0.000
F11.2 Dependence syndrome	0.004	0.996	0.000
F11.0 Acute intoxication	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.003	0.996	0.000
Z29 Need for other prophylactic measures	0.004	0.996	0.000
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.004	0.996	0.000
F11.3 Withdrawal state	0.003	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.996	0.000
F10.2 Dependence syndrome	0.004	0.996	0.000
N89.7 Haematocolpos	0.000	0.996	0.003
N89.4 Leukoplakia of vagina	0.000	0.996	0.003
N89.3 Dysplasia of vagina, unspecified	0.000	0.996	0.003
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.000	0.996	0.003
N89.1 Moderate vaginal dysplasia	0.000	0.996	0.003
N89.0 Mild vaginal dysplasia	0.000	0.996	0.003
F11.1 Harmful use	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.003	0.997	0.000
Z29.1 Prophylactic immunotherapy	0.003	0.997	0.000
L50.0 Allergic urticaria	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
L81 Other disorders of pigmentation	0.003	0.997	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.003	0.997	0.000
F80 Specific developmental disorders of speech and language	0.003	0.997	0.000
F11.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F11.8 Other mental and behavioural disorders	0.003	0.997	0.000
F11.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F11.6 Amnesic syndrome	0.003	0.997	0.000
F11.5 Psychotic disorder	0.003	0.997	0.000
F11.4 Withdrawal state with delirium	0.003	0.997	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.003	0.997	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.003	0.997	0.000
F19.2 Dependence syndrome	0.003	0.997	0.000
E15 Nondiabetic hypoglycaemic coma	0.003	0.997	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.003	0.997	0.000
F80.2 Receptive language disorder	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Z29.9 Prophylactic measure, unspecified	0.003	0.997	0.000
F12.1 Harmful use	0.003	0.997	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
F19.1 Harmful use	0.003	0.997	0.000
F10.5 Psychotic disorder	0.003	0.997	0.000
F05.9 Delirium, unspecified	0.003	0.997	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.003	0.997	0.000
F10.0 Acute intoxication	0.003	0.997	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.003	0.997	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.003	0.997	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.003	0.997	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.003	0.997	0.000
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.003	0.997	0.000
M79.54 Residual foreign body in soft tissue (Hand)	0.003	0.997	0.000
F10.6 Amnesic syndrome	0.003	0.997	0.000
F10.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F12.2 Dependence syndrome	0.002	0.997	0.000
F19.9 Unspecified mental and behavioural disorder	0.002	0.997	0.000
F19.8 Other mental and behavioural disorders	0.002	0.997	0.000
F19.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
F19.6 Amnesic syndrome	0.002	0.997	0.000
F19.5 Psychotic disorder	0.002	0.997	0.000
F19.4 Withdrawal state with delirium	0.002	0.997	0.000
F19.3 Withdrawal state	0.002	0.997	0.000
F19.0 Acute intoxication	0.002	0.997	0.000
L81.7 Pigmented purpuric dermatosis	0.002	0.997	0.000
L81.6 Other disorders of diminished melanin formation	0.002	0.997	0.000
L81.5 Leukoderma, not elsewhere classified	0.002	0.997	0.000
L81.3 Cafe au lait spots	0.002	0.997	0.000
L81.1 Chloasma	0.002	0.997	0.000
L81.0 Postinflammatory hyperpigmentation	0.002	0.997	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.002	0.997	0.000
F80.8 Other developmental disorders of speech and language	0.002	0.997	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.002	0.997	0.000
F80.0 Specific speech articulation disorder	0.002	0.997	0.000
F10.8 Other mental and behavioural disorders	0.002	0.997	0.000
F10.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.997	0.003
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.997	0.002
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.003	0.997	0.000
F12.9 Unspecified mental and behavioural disorder	0.002	0.997	0.000
F12.8 Other mental and behavioural disorders	0.002	0.997	0.000
F12.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
F12.6 Amnesic syndrome	0.002	0.997	0.000
F12.5 Psychotic disorder	0.002	0.997	0.000
F12.4 Withdrawal state with delirium	0.002	0.997	0.000
F12.3 Withdrawal state	0.002	0.997	0.000
F12.0 Acute intoxication	0.002	0.997	0.000
F43 Reaction to severe stress, and adjustment disorders	0.002	0.997	0.000
F15.1 Harmful use	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
O80.9 Single spontaneous delivery, unspecified	0.002	0.998	0.000
D10.3 Other and unspecified parts of mouth	0.000	0.998	0.002
F32.3 Severe depressive episode with psychotic symptoms	0.002	0.998	0.000
F15.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F15.8 Other mental and behavioural disorders	0.002	0.998	0.000
F15.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F15.6 Amnesic syndrome	0.002	0.998	0.000
F15.5 Psychotic disorder	0.002	0.998	0.000
F15.4 Withdrawal state with delirium	0.002	0.998	0.000
F15.3 Withdrawal state	0.002	0.998	0.000
F15.2 Dependence syndrome	0.002	0.998	0.000
F15.0 Acute intoxication	0.002	0.998	0.000
L81.8 Other specified disorders of pigmentation	0.002	0.998	0.000
L81.2 Freckles	0.002	0.998	0.000
Z36.8 Other antenatal screening	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
F52.2 Failure of genital response	0.000	0.998	0.002
D03.5 Melanoma in situ of trunk	0.000	0.998	0.002
F13.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F13.8 Other mental and behavioural disorders	0.002	0.998	0.000
F13.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F13.6 Amnesic syndrome	0.002	0.998	0.000
F13.5 Psychotic disorder	0.002	0.998	0.000
F13.4 Withdrawal state with delirium	0.002	0.998	0.000
F13.3 Withdrawal state	0.002	0.998	0.000
F13.2 Dependence syndrome	0.002	0.998	0.000
F13.1 Harmful use	0.002	0.998	0.000
F13.0 Acute intoxication	0.002	0.998	0.000
F14.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F14.8 Other mental and behavioural disorders	0.002	0.998	0.000
F14.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F14.6 Amnesic syndrome	0.002	0.998	0.000
F14.5 Psychotic disorder	0.002	0.998	0.000
F14.4 Withdrawal state with delirium	0.002	0.998	0.000
F14.3 Withdrawal state	0.002	0.998	0.000
F14.2 Dependence syndrome	0.002	0.998	0.000
F14.1 Harmful use	0.002	0.998	0.000
F14.0 Acute intoxication	0.002	0.998	0.000
F16.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F16.8 Other mental and behavioural disorders	0.002	0.998	0.000
F16.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F16.6 Amnesic syndrome	0.002	0.998	0.000
F16.5 Psychotic disorder	0.002	0.998	0.000
F16.4 Withdrawal state with delirium	0.002	0.998	0.000
F16.3 Withdrawal state	0.002	0.998	0.000
F16.2 Dependence syndrome	0.002	0.998	0.000
F16.1 Harmful use	0.002	0.998	0.000
F16.0 Acute intoxication	0.002	0.998	0.000
F18.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F18.8 Other mental and behavioural disorders	0.002	0.998	0.000
F18.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F18.6 Amnesic syndrome	0.002	0.998	0.000
F18.5 Psychotic disorder	0.002	0.998	0.000
F18.4 Withdrawal state with delirium	0.002	0.998	0.000
F18.3 Withdrawal state	0.002	0.998	0.000
F18.2 Dependence syndrome	0.002	0.998	0.000
F18.1 Harmful use	0.002	0.998	0.000
F18.0 Acute intoxication	0.002	0.998	0.000
F43.1 Posttraumatic stress disorder	0.002	0.998	0.000
K63.3 Ulcer of intestine	0.000	0.998	0.002
F10.3 Withdrawal state	0.002	0.998	0.000
F43.9 Reaction to severe stress, unspecified	0.002	0.998	0.000
R41.0 Disorientation, unspecified	0.002	0.998	0.000
F10.4 Withdrawal state with delirium	0.002	0.998	0.000
F43.8 Other reactions to severe stress	0.002	0.998	0.000
D36 Benign neoplasm of other and unspecified sites	0.000	0.998	0.002
F80-F89 Disorders of psychological development	0.002	0.998	0.000
Z29.0 Isolation	0.002	0.998	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
F44 Dissociative [conversion] disorders	0.002	0.998	0.000
L81.9 Disorder of pigmentation, unspecified	0.002	0.998	0.000
D73.0 Hyposplenism	0.002	0.998	0.000
O82.0 Delivery by elective Caesarean section	0.002	0.998	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.000	0.998	0.002
I81 Portal vein thrombosis	0.002	0.998	0.000
F44.8 Other dissociative [conversion] disorders	0.002	0.998	0.000
F44.4 Dissociative motor disorders	0.002	0.998	0.000
D63 Anaemia in chronic diseases classified elsewhere	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
D63.0 Anaemia in neoplastic disease	0.002	0.998	0.000
W22.9 Unspecified place	0.002	0.998	0.000
D36.0 Lymph nodes	0.000	0.998	0.002
F44.5 Dissociative convulsions	0.002	0.998	0.000
F44.0 Dissociative amnesia	0.002	0.998	0.000
O82.1 Delivery by emergency Caesarean section	0.002	0.998	0.000
Z90.4 Acquired absence of other parts of digestive tract	0.000	0.998	0.002
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.000	0.998	0.002
C84.4 Peripheral T-cell lymphoma	0.002	0.998	0.000
F44.9 Dissociative [conversion] disorder, unspecified	0.002	0.998	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.001
K46 Unspecified abdominal hernia	0.002	0.998	0.000
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.002	0.998	0.000
F89 Unspecified disorder of psychological development	0.001	0.998	0.000
F88 Other disorders of psychological development	0.001	0.998	0.000
F83 Mixed specific developmental disorders	0.001	0.998	0.000
F82 Specific developmental disorder of motor function	0.001	0.998	0.000
F05.0 Delirium not superimposed on dementia, so described	0.002	0.998	0.000
F48.0 Neurasthenia	0.002	0.998	0.000
F05.1 Delirium superimposed on dementia	0.002	0.998	0.000
F44.7 Mixed dissociative [conversion] disorders	0.001	0.998	0.000
F44.6 Dissociative anaesthesia and sensory loss	0.001	0.998	0.000
F44.3 Trance and possession disorders	0.001	0.998	0.000
F44.2 Dissociative stupor	0.001	0.998	0.000
F44.1 Dissociative fugue	0.001	0.998	0.000
M18.1 Other primary arthrosis of first carpometacarpal joint	0.002	0.998	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.998	0.002
F84 Pervasive developmental disorders	0.001	0.998	0.000
N97.9 Female infertility, unspecified	0.002	0.998	0.000
T40.2 Other opioids	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.001	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.001	0.998	0.000
T42.3 Barbiturates	0.001	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.001	0.998	0.000
E26 Hyperaldosteronism	0.002	0.998	0.000
S82.30 Fracture of lower end of tibia (closed)	0.002	0.998	0.000
D63.1 Anaemia in other chronic diseases classified elsewhere	0.001	0.998	0.000
F22.0 Delusional disorder	0.002	0.998	0.000
F48 Other neurotic disorders	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.001	0.998	0.000
E26.9 Hyperaldosteronism, unspecified	0.001	0.998	0.000
F43.0 Acute stress reaction	0.001	0.998	0.000
N90.4 Leukoplakia of vulva	0.002	0.998	0.000
E20 Hypoparathyroidism	0.001	0.998	0.000
E20-E35 Disorders of other endocrine glands	0.002	0.998	0.000
E26.0 Primary hyperaldosteronism	0.001	0.998	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.001	0.998	0.000
M70.46 Prepatellar bursitis-Lower Leg	0.001	0.998	0.000
F05.8 Other delirium	0.001	0.998	0.000
K75.4 Autoimmune hepatitis	0.002	0.998	0.000
O82 Single delivery by Caesarean section	0.002	0.998	0.000
D36.9 Benign neoplasm of unspecified site	0.000	0.998	0.001
D73.5 Infarction of spleen	0.001	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.001
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.001
F52.7 Excessive sexual drive	0.000	0.998	0.001
F52.6 Nonorganic dyspareunia	0.000	0.998	0.001
F52.5 Nonorganic vaginismus	0.000	0.998	0.001
F52.4 Premature ejaculation	0.000	0.998	0.001
F52.3 Orgasmic dysfunction	0.000	0.998	0.001
F52.1 Sexual aversion and lack of sexual enjoyment	0.000	0.998	0.001
F52.0 Lack or loss of sexual desire	0.000	0.998	0.001
R41.1 Anterograde amnesia	0.001	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.001	0.998	0.000
F01.9 Vascular dementia, unspecified	0.001	0.998	0.000
K46.1 Unspecified abdominal hernia with gangrene	0.001	0.998	0.000
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.001	0.998	0.000
N73.6 Female pelvic peritoneal adhesions	0.000	0.998	0.002
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.001	0.998	0.000
F10.1 Harmful use	0.001	0.999	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.001	0.999	0.000
D06.9 Cervix, unspecified	0.001	0.999	0.000
F84.9 Pervasive developmental disorder, unspecified	0.001	0.999	0.000
F84.8 Other pervasive developmental disorders	0.001	0.999	0.000
F84.4 Overactive disorder associated with mental retardation and stereotyped movements	0.001	0.999	0.000
F84.3 Other childhood disintegrative disorder	0.001	0.999	0.000
F84.2 Rett's syndrome	0.001	0.999	0.000
F84.1 Atypical autism	0.001	0.999	0.000
F84.0 Childhood autism	0.001	0.999	0.000
O32.0 Maternal care for unstable lie	0.001	0.999	0.000
F01 Vascular dementia	0.001	0.999	0.000
R41 Other symptoms and signs involving cognitive functions and awareness	0.001	0.999	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.999	0.000
F48.9 Neurotic disorder, unspecified	0.001	0.999	0.000
F81 Specific developmental disorders of scholastic skills	0.001	0.999	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.001	0.999	0.000
E26.8 Other hyperaldosteronism	0.001	0.999	0.000
E26.1 Secondary hyperaldosteronism	0.001	0.999	0.000
F25.1 Schizoaffective disorder, depressive type	0.001	0.999	0.000
D73 Diseases of spleen	0.001	0.999	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.000	0.999	0.001
D36.7 Other specified sites	0.000	0.999	0.001
F48.8 Other specified neurotic disorders	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations